Short-course clinical research on combination therapy for AR by budesonide nasal irrigation and “helium-neon laser” therapy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023973

Enrollment

Unknown

Registered

2019-06-20

Start date

2019-07-15

Completion date

Unknown

Last updated

2019-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

A:Budesonide nasal irrigation

B:Saline flushing

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria for allergic rhinitis; 2.Previous physical health, no other treatment or have stopped treatment for more than 2 weeks; 3.The course of disease is 2-40 years, aged 18-70 years old; 4.Local medical insurance patients, volunteered to participate in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1.The nasal septum is biased; 2.Combined with sinusitis, intranasal mass, or other intranasal mucosal lesions; 3.Pregnant or lactating women; 4.Those with other respiratory diseases; 5.Suspected or indeed had a history of drug abuse.

Design outcomes

Primary

Measure	Time frame
Uni—VAS;RQLQ;	—

Countries

China

Contacts

Public ContactYue Sun

Peking University Shougang Hospital

sunyue1491@163.com+86 18811780329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026